SCHEMBL1995601

SCHEMBL1995601

[2H]C([2H])(OCc1ccccc1)c1ccc(OCc2ccccc2)c([C@H](CC(=O)N(C(C)C)C(C)C)c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
ALOX5 P09917 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.37
APP P05067 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
FFAR1 O14842 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ACP1 P24666 1/20 0.36
PTPN12 Q05209 1/20 0.36
PTPN13 Q12923 1/20 0.36
SSU72 Q9NP77 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
FOLH1 Q04609 1/20 0.36
CCR5 P51681 1/20 0.36
PDE4A P27815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990015 0.89 ACP1 (0.37) CHRM2CHRM1ALOX5TRPM8APP
SCHEMBL1989783 0.87 KMT2A (0.44) FFAR4FFAR1ACP1PTPN12PTPN13
SCHEMBL1999507 0.84 FOLH1 (0.39) FFAR4FFAR1KDM4ELMNAALDH1A1
SCHEMBL13257883 0.84 KMT2A (0.47) CHRM2CHRM1ALOX5FFAR4KDM4E
SCHEMBL12986736 0.84 KMT2A (0.47) CHRM2CHRM1ALOX5FFAR4KDM4E
SCHEMBL1991544 0.84 KMT2A (0.40) CHRM2CHRM1ALOX5TRPM8APP
SCHEMBL2167293 0.83 LMNA (0.47) LMNAALDH1A1MAPTCCR5
SCHEMBL14830823 0.83 LMNA (0.47) LMNAALDH1A1MAPTCCR5
SCHEMBL2167132 0.83 LMNA (0.47) LMNAALDH1A1MAPTCCR5
SCHEMBL1991264 0.82 ACP1 (0.38) CHRM2CHRM1ALOX5TRPM8APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR CHRM2 19/4885CHRM1 63/4885ALOX5 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.